Skip to content
thispeptide

Vitakey

Vitakey promises continuity with the same provider and direct messages, but its public pages do not identify the clinician or pharmacy assigned to a patient. Confirm those details before choosing a recovery or weight-management program.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Ask who will assess and monitor the treatment, and how the continuity promise works if the clinician changes. A polished care illustration is not a verified appointment or clinical result.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Peptivo LLC operates Vitakey as a platform connecting patients with independent clinicians and pharmacies. The interactive catalog lists compounded GLP-1 products alongside NAD, glutathione, sermorelin and tesamorelin. A provider reviews the history before prescribing. Different preparations and goals need separate clinical justification, even when offered through the same catalog.

What Vitakey prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      The catalog separates a one-month option from longer supplies and dose tiers. Ask how the actual compounded preparation and titration plan fit your history. An average outcome displayed in the interface does not predict the individual result or establish the quality of the monitoring.

      Longevity

      • NAD+Compounding conditions apply

        Listed by the seller; no price we hold.

        • GlutathioneCompounding conditions apply

          Listed by the seller; no price we hold.

          NAD, glutathione and growth-hormone-related products are promoted for energy, recovery and aging goals. Those goals do not establish a benefit for every preparation or patient. Ask which evidence supports the proposed treatment and how its effects will be assessed.

          Recovery

          • SermorelinCompounding conditions apply

            Listed by the seller; no price we hold.

            Sleep

            • SermorelinCompounding conditions apply

              Listed by the seller; no price we hold.

              Who prescribes

              A licensed clinician

              The site does not name the assigned prescriber, a specific clinical practice or the guaranteed dispensing pharmacy in its public care agreement. The terms place assessment, testing and prescribing with independent licensed professionals. A homepage notification naming a doctor is an interface illustration rather than an established assignment. Ask for your clinician’s identity and the actual pharmacy before medication is prepared.

              An online intake precedes provider review, with a stated twenty-four- to forty-eight-hour assessment window. Terms allow questionnaires, secure messages and live consultation where applicable. The site promises check-ins and messages with the same provider. Ask which reassessments are scheduled and what happens during absence or transfer. The terms permit requests for tests, in-person care or specialist referral when necessary.

              Are labs required?

              Not mentioned

              The terms allow the clinician to request laboratory work but do not establish one universal included testing panel. Ask whether existing results suffice, what new tests cost and who reviews them before continuation. More laboratory guidance does not by itself establish better outcomes. Follow-up should respond to the actual clinical findings.

              Ready to start with Vitakey?

              Prices and plans are set on the seller's own site.

              What it claims, and what it cites

              The homepage claims a high degree of provider continuity and presents example messages, delivery notices and outcome figures. Those displays do not establish a particular patient’s experience. The catalog’s recovery and longevity descriptions also require preparation-specific evidence. The provider should explain uncertainties and alternatives rather than relying on biological mechanisms or a flat-price promise.

              Other products and treatment claims

              Tesamorelin
              Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
              Illustrative interface messages as clinician identification
              A displayed doctor notification does not establish who will personally review or monitor a patient.

              How it bills

              The catalog distinguishes one-month choices from three-month plans, with separate higher-dose tiers on longer GLP-1 supplies. Public cancellation copy differs between dashboard promises and a contact-based policy. The initial evaluation is described as free, while completed later consultation fees may be nonrefundable. Confirm the actual clinical services and product agreement before payment.

              For and against

              • For: Actual platform operator identified
              • For: Clinical decisions reserved to independent professionals
              • For: Provider messaging and continuity described
              • For: Testing or in-person referral permitted
              • Against: Assigned professional and pharmacy not identified
              • Against: Scheduled monitoring cadence needs confirmation
              • Against: Recovery claims require preparation-specific evidence
              • Against: Interface examples do not establish real clinical outcomes

              The evidence behind what it sells

              Right for

              Someone who will verify the actual professional and follow-up agreement behind a continuity-of-care promise.

              Look elsewhere if

              Someone assuming an illustrated doctor message or average result identifies their clinician or predicts their outcome.

              Other sellers for weight

              Vitakey

              Frequently asked questions

              Does the example doctor notification identify my actual prescriber?
              No. Confirm the professional assigned to assess and monitor your treatment.
              Does the continuity promise establish a fixed visit schedule?
              No universal schedule is established. Ask which reassessments are included and who provides coverage.
              Is every laboratory test included?
              The terms permit necessary testing but do not establish one universal included panel.

              Sources

              • Care model, support claims and actual operator
              • Current interactive treatment catalog and selected supply options
              • Independent clinicians, pharmacies and payment scope
              • Cancellation methods and consultation refund boundaries

              See what Vitakey prescribes today

              Vitakey sets its own prices, plans and the states it serves. Check them before you start.

              Written by Molly Ward from Vitakey’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.